Literature DB >> 9833891

Three-dimensional CT angiography of intracranial vasospasm following subarachnoid haemorrhage.

R Takagi1, H Hayashi, H Kobayashi, T Kumazaki, K Isayama, Y Ikeda, A Teramoto.   

Abstract

We evaluated the usefulness of three-dimensional CT angiography (3D-CTA) in the diagnosis of intracranial vasospasm following subarachnoid haemorrhage (SAH) in 13 patients suspected of having vasospasm on clinical grounds. The intracranial vessels were clearly shown by 3D-CTA in 12 patients. 3D-CTA revealed spasm in the vessels of nine patients. Catheter angiography performed in seven of these patients immediately after 3D-CTA confirmed vasospasm. A low-attenuation area was seen on CT in the other two patients, representing an ischaemic lesion due to the spasm. In nine patients, a second 3D-CTA was performed using the same technique 1 week after the first, showing no vasospasm. Initial 3D-CTA revealed no vasospasm change in three patients. Following 3D-CTA, one of these had conventional angiography, which also demonstrated no spasm.

Entities:  

Mesh:

Year:  1998        PMID: 9833891     DOI: 10.1007/s002340050654

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  12 in total

1.  Diagnostic accuracy of CT angiography and CT perfusion for cerebral vasospasm: a meta-analysis.

Authors:  E D Greenberg; R Gold; M Reichman; M John; J Ivanidze; A M Edwards; C E Johnson; J P Comunale; P Sanelli
Journal:  AJNR Am J Neuroradiol       Date:  2010-09-30       Impact factor: 3.825

2.  CT angiography for the detection of cerebral vasospasm in patients with acute subarachnoid hemorrhage.

Authors:  G B Anderson; R Ashforth; D E Steinke; J M Findlay
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

Review 3.  Management of cerebral vasospasm.

Authors:  R Loch Macdonald
Journal:  Neurosurg Rev       Date:  2006-02-24       Impact factor: 3.042

4.  Role of multisection CT angiography in the evaluation of vertebrobasilar vasospasm in patients with subarachnoid hemorrhage.

Authors:  Dorith Goldsher; Reuven Shreiber; Venyamin Shik; Yonit Tavor; Jean F Soustiel
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

5.  Acute subarachnoid hemorrhage: using 64-slice multidetector CT angiography to "triage" patients' treatment.

Authors:  R Agid; S K Lee; R A Willinsky; R I Farb; K G terBrugge
Journal:  Neuroradiology       Date:  2006-09-29       Impact factor: 2.804

6.  CT angiography for evaluation of cerebral vasospasm following acute subarachnoid haemorrhage.

Authors:  Jai Jai Shiva Shankar; Irene Y L Tan; Timo Krings; Karel Terbrugge; Ronit Agid
Journal:  Neuroradiology       Date:  2011-05-04       Impact factor: 2.804

7.  Multidetector-row CT angiography of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: comparison of volume-rendered images and digital subtraction angiography.

Authors:  D Y Yoon; C S Choi; K H Kim; B-M Cho
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

8.  Endothelin-1 expression and alterations of cerebral microcirculation after experimental subarachnoid hemorrhage.

Authors:  Qin Lei; Shu Li; Ruibin Zheng; Ke Xu; Songbai Li
Journal:  Neuroradiology       Date:  2014-10-05       Impact factor: 2.804

9.  Reliability of CT Angiography in Cerebral Vasospasm: A Systematic Review of the Literature and an Inter- and Intraobserver Study.

Authors:  L Letourneau-Guillon; B Farzin; T E Darsaut; M Kotowski; F Guilbert; M Chagnon; A Diouf; D Roy; A Weill; M Lemus; C Bard; M Belair; D Landry; L Nico; A Tellier; R Jabre; C Kauffmann; J Raymond
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-26       Impact factor: 3.825

10.  The value of CT angiography and transcranial doppler sonography in triaging suspected cerebral vasospasm in SAH prior to endovascular therapy.

Authors:  Catalina C Ionita; Carmelo Graffagnino; Michael J Alexander; Osama O Zaidat
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.